 Deutsche Bank AG reduced its position in shares of Dicerna Pharmaceuticals Inc NASDAQ:DRNA by 62.7 in the 1st quarter, according to its most recent filing with the Securities Exchange Commission. The fund owned 20,168 shares of the biopharmaceutical companys stock after selling 33,866 shares during the period. Deutsche Bank AGs holdings in Dicerna Pharmaceuticals ... 